Trial Outcomes & Findings for Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial (NCT NCT03052920)

NCT ID: NCT03052920

Last Updated: 2022-01-12

Results Overview

Group mean difference in CNC monosyllabic word understanding score in quiet with the CI alone at 6 months post-implant compared to pre-implant with a hearing aid. (CNC scored on a scale from 0% to 100%; Higher scores are better.)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

40 participants

Primary outcome timeframe

Pre-implant and 6 months post-implant

Results posted on

2022-01-12

Participant Flow

Recruitment occurred from Summer 2017 through 2019.

Participant milestones

Participant milestones
Measure
Cochlear Implantation
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Overall Study
STARTED
40
Overall Study
COMPLETED
39
Overall Study
NOT COMPLETED
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Cochlear Implantation
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Overall Study
Withdrawal by Subject
1

Baseline Characteristics

Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Cochlear Implantation
n=40 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
n=5 Participants
Age, Categorical
>=65 years
30 Participants
n=5 Participants
Age, Continuous
68.96 years
STANDARD_DEVIATION 10.27 • n=5 Participants
Sex: Female, Male
Female
17 Participants
n=5 Participants
Sex: Female, Male
Male
23 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
35 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
Race (NIH/OMB)
White
33 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
n=5 Participants
Region of Enrollment
United States
40 Participants
n=5 Participants
Length of Deafness - Poor Ear
10.18 years
STANDARD_DEVIATION 12.06 • n=5 Participants

PRIMARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 36 participants had both pre-implant and 6-month post-implant CNC scores for the poor ear alone.

Group mean difference in CNC monosyllabic word understanding score in quiet with the CI alone at 6 months post-implant compared to pre-implant with a hearing aid. (CNC scored on a scale from 0% to 100%; Higher scores are better.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=36 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Poor Ear Alone CNC Monosyllabic Word Understanding in Quiet
Pre-Implant Mean
0.09 percentage of words correct
Standard Error 0.016
Change in Poor Ear Alone CNC Monosyllabic Word Understanding in Quiet
6 Month Post-Implant Mean
0.53 percentage of words correct
Standard Error 0.422
Change in Poor Ear Alone CNC Monosyllabic Word Understanding in Quiet
Group mean difference
0.44 percentage of words correct
Standard Error 0.039

PRIMARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 36 participants had both pre-implant and 6-month post-implant Soundfield thresholds for the poor ear alone.

Group mean difference in soundfield thresholds (dB HL average across frequency range) with the CI alone at 6 months post-implant compared to pre-implant with a hearing aid. (Measurable decibels in hearing level (dB HL) generally range from -10 dB to 120 dB; Lower levels are better.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=36 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Poor Ear Alone Soundfield Thresholds
6 Month Post-Implant Mean
26.54 Decibels
Standard Error 1.03
Change in Poor Ear Alone Soundfield Thresholds
Pre-Implant Mean
54.95 Decibels
Standard Error 1.72
Change in Poor Ear Alone Soundfield Thresholds
Group mean difference
28.41 Decibels
Standard Error 1.68

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 36 participants had both pre-implant and 6-month localization scores in the bilateral/bimodal condition

Sound localization in RMS error at 6-months post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition. (Root Mean Error Scores in degrees of error can range from 0 to approximately 80 degrees. Chance level performance is 64 degrees. Lower scores indicate better performance.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=36 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Sound Localization
Pre-Implant Mean
45.05 degrees RMS error
Standard Error 2.79
Change in Sound Localization
6 Month Post-Implant Mean
39.07 degrees RMS error
Standard Error 1.57
Change in Sound Localization
Group Mean Difference
5.99 degrees RMS error
Standard Error 2.80

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: Both pre-implant and 6-month post-implant data were available for 36 participants.

Understanding of sentences at a soft presentation level at 6-months post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition. (Percent correct ranging from 0 to 100%; Higher scores indicate better performance.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=36 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in AzBio Sentences at 50 Decibels (dB) Sound Pressure Level (SPL)
Pre-Implant Mean
66.81 percentage of words correct
Standard Error 4.56
Change in AzBio Sentences at 50 Decibels (dB) Sound Pressure Level (SPL)
6-month Post-implant Mean
83.06 percentage of words correct
Standard Error 3.14
Change in AzBio Sentences at 50 Decibels (dB) Sound Pressure Level (SPL)
Group mean difference
16.25 percentage of words correct
Standard Error 4.04

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 36 participants had both pre-implant and 6-mongh post-implant AzBio scores in noise.

Group mean difference in understanding of sentences in noise at 6-months post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition. (Percent correct scoring ranging from 0 - 100%; Higher scores indicate better performance.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=36 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in AzBio Sentence Scores at 60 dB SPL and 4-talker Babble at +8 dB Signal-to-noise Ratio (SNR)
Pre-Implant Mean
64.39 percentage of words correct
Standard Error 4.16
Change in AzBio Sentence Scores at 60 dB SPL and 4-talker Babble at +8 dB Signal-to-noise Ratio (SNR)
6-Month Post-Implant Mean
71.42 percentage of words correct
Standard Error 3.87
Change in AzBio Sentence Scores at 60 dB SPL and 4-talker Babble at +8 dB Signal-to-noise Ratio (SNR)
Group Mean Difference
7.03 percentage of words correct
Standard Error 2.72

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 36 participants had BKB-SIN scores for noise to the better ear at both the pre-implant and 6-month test intervals

Group mean difference in BKB-SIN scores in noise (dB SNR) 6-months post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition. Speech is from the front and noise to the better ear. (Scores are the signal to noise ration in decibels for approximately 50% understanding and can range from -7.5 dB to 23.5 dB; Lower scores indicate better performance.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=36 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentence Understanding With Noise to the Better Ear
Pre-implant mean
6.61 dB Signal-to-Noise Ratio
Standard Error 0.83
Change in Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentence Understanding With Noise to the Better Ear
6-month post-implant mean
4.06 dB Signal-to-Noise Ratio
Standard Error 0.83
Change in Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentence Understanding With Noise to the Better Ear
Group mean difference
2.56 dB Signal-to-Noise Ratio
Standard Error 0.81

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 36 participants had poor ear alone AzBio sentence scores at both the pre-implant and 6-month test intervals.

Group mean difference in AzBio sentence scores in quiet for the poor ear alone with the CI at 6-months post-implant compared to pre-implant with a hearing aid. (Scores are percent of words correct and can range from 0 to 100%; higher scores indicate better performance.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=36 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in AzBio Sentence Scores at 60 dB SPL for the Poor Ear Alone
Pre-implant mean
13.97 percentage of words correct
Standard Error 2.75
Change in AzBio Sentence Scores at 60 dB SPL for the Poor Ear Alone
6-month post-implant mean
64.86 percentage of words correct
Standard Error 4.96
Change in AzBio Sentence Scores at 60 dB SPL for the Poor Ear Alone
Group mean difference
50.89 percentage of words correct
Standard Error 4.89

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 39 participants had completed the HHIE at both the pre-implant and 6-month post-implant test intervals.

Inventory completed by participant regarding emotional and social consequences of hearing loss. Group mean difference in the total HHIE ratings at 6-months post-implant compared to pre-implant. (Ratings can range from 0 to 100; Lower scores indicate less perceived hearing handicap - lower scores are better.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=39 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Hearing Handicap Inventory (HHIE)
Pre-implant mean
0.67 score on a scale
Standard Error 0.03
Change in Hearing Handicap Inventory (HHIE)
6-months post-implant mean
0.46 score on a scale
Standard Error 0.04
Change in Hearing Handicap Inventory (HHIE)
Group mean difference
0.21 score on a scale
Standard Error 0.03

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 39 participants completed the HUI3 at both the pre-implant and 6-month post-implant test intervals.

Questionnaire completed by participant regarding ability/disability across several health dimensions. Group mean difference in HUI3 ratings (total score) at 6 months post-implant compared to pre-implant. (Scores can range from 0.0 to 1.0; Higher scores indicate greater perceived health/ability.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=39 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Health Utility Index (HUI3) Ratings
Pre-implant mean
0.51 score on a scale
Standard Error 0.04
Change in Health Utility Index (HUI3) Ratings
6-month post-implant mean
0.66 score on a scale
Standard Error 0.03
Change in Health Utility Index (HUI3) Ratings
Group mean difference
0.15 score on a scale
Standard Error 0.03

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 39 participants had SSQ ratings at both the pre-implant and 6-month test intervals.

Questionnaire completed by participant regarding impact of hearing loss on various listening situations. Group mean difference in SSQ ratings at 6-months post-implant compared to pre-implant. (Ratings can range from 0 to 10; Higher scores indicate greater perceived abilities.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=39 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Speech, Spatial and Sound Qualities (SSQ) by 6-months Post-implant
Pre-implant mean
3.42 score on a scale
Standard Error 0.23
Change in Speech, Spatial and Sound Qualities (SSQ) by 6-months Post-implant
6-month post-implant mean
5.46 score on a scale
Standard Error 0.22
Change in Speech, Spatial and Sound Qualities (SSQ) by 6-months Post-implant
Group mean difference
2.03 score on a scale
Standard Error 0.26

SECONDARY outcome

Timeframe: Pre-implant and 12 months post-implant

Population: 39 participants had SSQ ratings for both the pre-implant and 12-month post-implant test intervals. (These were not the same 39 who had SSQ ratings at both the 6-month and pre-implant test intervals.)

Questionnaire completed by participant regarding impact of hearing loss on various listening situations. Group mean difference in SSQ ratings at 12-months post-implant compared to pre-implant. (Ratings can range from 0 to 10; Higher scores indicate greater perceived abilities.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=39 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Speech, Spatial and Sound Qualities (SSQ) by 12-months Post-implant
Pre-implant mean
3.37 score on a scale
Standard Error 0.23
Change in Speech, Spatial and Sound Qualities (SSQ) by 12-months Post-implant
12-month post-implant mean
5.37 score on a scale
Standard Error 0.25
Change in Speech, Spatial and Sound Qualities (SSQ) by 12-months Post-implant
Group mean difference
2.00 score on a scale
Standard Error 0.25

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 39 participants completed the HA version of the SADL pre-implant and also the bimodal version at 6 months post-implant (a modification of the original SADL).

Questionnaire completed by participant regarding satisfaction of HA use (pre-implant) and bimodal (HA+CI) device use at 6 months post-implant. (Ratings can range from 1 to 7; Higher scores indicate greater satisifaction.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=39 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Satisfaction With Amplification in Daily Use (SADL)
Pre-implant mean
4.88 score on a scale
Standard Error 0.12
Change in Satisfaction With Amplification in Daily Use (SADL)
6-month post-implant mean
5.36 score on a scale
Standard Error 0.15
Change in Satisfaction With Amplification in Daily Use (SADL)
Group mean difference
0.48 score on a scale
Standard Error 0.20

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 26 participants had a spouse or significant other who completed the CPHI at both the pre-implant and 6-month post-implant test intervals.

The CPHI was completed by participant's spouse/significant other indicating their perception of how well the participant communicates in various situations. Group mean difference in CPHI ratings at 6 months post-implant compared to pre-implant. (Ratings can range from 1 to 5; Higher scores indicate better communication abilities as perceived by the spouse/significant other.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=26 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Scores on the Communication Profile for the Hearing Impaired (CPHI)
Pre-implant mean
2.27 score on a scale
Standard Error 0.10
Change in Scores on the Communication Profile for the Hearing Impaired (CPHI)
6-month post-implant mean
3.50 score on a scale
Standard Error 0.15
Change in Scores on the Communication Profile for the Hearing Impaired (CPHI)
Group mean difference
1.22 score on a scale
Standard Error 0.17

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 26 participants had a spouse or significant other who completed the HII-SOP at both the pre-implant and 6 month post-implant test intervals.

Questionnaire completed by participant's spouse/significant other indicating their perception of the impact of the participant's hearing loss on the spouse/significant other. Group mean difference in HII-SOP scores at 6 months post-implant compared to pre-implant. (Scores can range from 0 - 100; Lower scores are better - less impact of the hearing loss on the spouse/significant other.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=26 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Hearing Impaired Impact - Significant Other Profile (HII-SOP) by 6 Months Post-implant
Pre-implant mean
55.96 score on a scale
Standard Error 4.71
Change in Hearing Impaired Impact - Significant Other Profile (HII-SOP) by 6 Months Post-implant
6-month post-implant mean
22.98 score on a scale
Standard Error 4.63
Change in Hearing Impaired Impact - Significant Other Profile (HII-SOP) by 6 Months Post-implant
Group mean difference
32.98 score on a scale
Standard Error 4.31

SECONDARY outcome

Timeframe: Pre-implant and 6 months post-implant

Population: 36 participants had BKB-SIN scores for noise to the poor ear at both the pre-implant and 6-month test intervals

Group mean difference in BKB-SIN scores in noise (dB SNR) 6-months post-implant in the CI+HA (CI at poor ear; HA at better ear) condition compared to the pre-implant best aided condition. Speech is from the front and noise to the poor ear. (Scores are the signal to noise ration in decibels for approximately 50% understanding and can range from -7.5 dB to 23.5 dB; Lower scores indicate better performance.)

Outcome measures

Outcome measures
Measure
Cochlear Implantation
n=36 Participants
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Change in Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentence Understanding With Noise to the Poor Ear
Pre-implant mean
1.82 dB Signal-to-Noise Ratio
Standard Error 0.72
Change in Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentence Understanding With Noise to the Poor Ear
6-month post-implant mean
0.42 dB Signal-to-Noise Ratio
Standard Error 0.78
Change in Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) Sentence Understanding With Noise to the Poor Ear
Group mean difference
1.40 dB Signal-to-Noise Ratio
Standard Error 0.60

Adverse Events

Cochlear Implantation

Serious events: 8 serious events
Other events: 11 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Cochlear Implantation
n=40 participants at risk
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Vascular disorders
Stroke
2.5%
1/40 • Number of events 1 • Approximately 15 months, from enrollment until 12-month evaluation.
Infections and infestations
Infection
2.5%
1/40 • Number of events 1 • Approximately 15 months, from enrollment until 12-month evaluation.
Vascular disorders
Coronary angioplasty and stint
2.5%
1/40 • Number of events 1 • Approximately 15 months, from enrollment until 12-month evaluation.
Gastrointestinal disorders
Gall bladder removal
2.5%
1/40 • Number of events 1 • Approximately 15 months, from enrollment until 12-month evaluation.
General disorders
Nausea
2.5%
1/40 • Number of events 1 • Approximately 15 months, from enrollment until 12-month evaluation.
Renal and urinary disorders
Kidney stone removal
2.5%
1/40 • Number of events 1 • Approximately 15 months, from enrollment until 12-month evaluation.
Musculoskeletal and connective tissue disorders
Tear of medial meniscus
2.5%
1/40 • Number of events 1 • Approximately 15 months, from enrollment until 12-month evaluation.
Cardiac disorders
Heart bypass surgery
2.5%
1/40 • Number of events 1 • Approximately 15 months, from enrollment until 12-month evaluation.

Other adverse events

Other adverse events
Measure
Cochlear Implantation
n=40 participants at risk
Cochlear implantation of the poor hearing ear Cochlear implant: Participants who have failed a BiCROS or bilateral hearing aid trial and otherwise meet inclusion criteria will receive a cochlear implant at the poor hearing ear. Post-implant, participants will continue use of a hearing aid at the better ear and the cochlear implant at the poor ear.
Ear and labyrinth disorders
Dizziness
17.5%
7/40 • Number of events 7 • Approximately 15 months, from enrollment until 12-month evaluation.
Ear and labyrinth disorders
Tinnitus
5.0%
2/40 • Number of events 2 • Approximately 15 months, from enrollment until 12-month evaluation.
Ear and labyrinth disorders
Swelling
5.0%
2/40 • Number of events 2 • Approximately 15 months, from enrollment until 12-month evaluation.

Additional Information

Jill B Firszt, PI

Washington University in St. Luis

Phone: 314-362-4760

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place